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Study	  Objectives:	  To	  determine	  prevalence	  and	  heritability	  of	  insomnia	  during	  middle/late	  childhood	  
and	  adolescence;	  examine	  longitudinal	  associations	  in	  insomnia	  over	  time;	  and	  assess	  the	  extent	  to	  
which	  genetic	  and	  environmental	  factors	  on	  insomnia	  remain	  stable,	  or	  whether	  new	  factors	  come	  
into	  play,	  across	  this	  developmental	  period.	  
Design:	  Longitudinal	  twin	  study.	  
Setting:	  Academic	  medical	  center.	  
Patients	  or	  Participants:	  There	  were	  739	  complete	  monozygotic	  twin	  pairs	  (52%)	  and	  672	  complete	  
dizygotic	   twin	   pairs	   (48%)	   initially	   enrolled	   and	  were	   followed	   up	   at	   three	   additional	   time	   points	  
(waves).	  Mode	  ages	  at	  each	  wave	  were	  8,	  10,	  14,	  and	  15	  y	  (ages	  ranged	  from	  8-­‐18	  y).	  	  
Interventions:	  None.	  
Measurements	  and	  Results:	  Clinical	  ratings	  of	  insomnia	  symptoms	  were	  assessed	  using	  the	  Child	  and	  
Adolescent	   Psychiatric	   Assessment	   (CAPA)	   by	   trained	   clinicians,	   and	   rated	   according	   to	  Diagnostic	  
and	  Statistical	  Manual	  of	  Mental	  Disorders	   (DSM)-­‐III-­‐R	  criteria	   for	  presence	  of	   ‘clinically	   significant	  
insomnia’,	   over	   four	   sequential	   waves.	   Insomnia	   symptoms	   were	   prevalent	   but	   significantly	  
decreased	  across	  the	  four	  waves	  (ranging	  from	  16.6%	  to	  31.2%).	  ‘Clinically	  significant	  insomnia’	  was	  
moderately	  heritable	  at	  all	  waves	  (h2	  range	  =	  14%	  to	  38%),	  and	  the	  remaining	  source	  of	  variance	  was	  
the	   nonshared	   environment.	   Multivariate	   models	   indicated	   that	   genetic	   influences	   at	   wave	   1	  
contributed	  to	  insomnia	  at	  all	  subsequent	  waves,	  and	  that	  new	  genetic	  influences	  came	  into	  play	  at	  
wave	   2,	   which	   further	   contributed	   to	   stability	   of	   symptoms.	   Nonshared	   environmental	   influences	  
were	  time-­‐specific.	  
Conclusion:	   Insomnia	   is	  prevalent	   in	  childhood	  and	  adolescence,	  and	   is	  moderately	  heritable.	   	  The	  
progression	  of	  insomnia	  across	  this	  developmental	  time	  period	  is	  influenced	  by	  stable	  as	  well	  as	  new	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genetic	  factors	  that	  come	  into	  play	  at	  wave	  2.	  Molecular	  genetic	  studies	  should	  now	  identify	  genes	  
related	  to	  insomnia	  progression	  during	  childhood	  and	  adolescence.	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Introduction	  
The	  transition	  from	  childhood	  to	  adolescence	  is	  accompanied	  by	  numerous	  physiological	  and	  social	  
changes.	  During	  this	  time,	  it	  is	  perhaps	  not	  surprising	  that	  sleep	  disturbances	  are	  common.1	  Indeed,	  
prevalence	  of	  insomnia	  symptoms	  has	  been	  estimated	  to	  range	  from	  4%	  to	  41%	  in	  early	  childhood	  
and	   adolescence,	   depending	   on	   sample,	   age,	   and	   mode	   of	   assessment.2–8	   Insomnia	   manifests	  
difficulties	  initiating	  or	  maintaining	  sleep,	  early	  morning	  awakening,	  or	  feeling	  that	  the	  sleep	  period	  
was	   non-­‐restorative	   or	   unrefreshing,	   with	   the	   sleep	   problem	   causing	   significant	   distress	   or	  
impairment.9	   Despite	   our	   knowledge	   that	   insomnia	   exists	   in	   early	   childhood	   and	   adolescence,	  we	  
know	  relatively	  little	  about	  its	  developmental	  course.	  In	  adults	  it	  has	  been	  demonstrated	  that	  when	  
insomnia	  reaches	  clinical	  significance,	  it	  is	  likely	  to	  persist	  over	  time.10	  Longitudinal	  studies	  in	  young	  
children	   and	   adolescents	   have	   provided	  mixed	   results	   regarding	   the	   persistence	   of	   insomnia	   over	  
time.	  A	  study	  of	  individuals	  aged	  12	  to	  18	  y	  demonstrated	  that	  more	  than	  50%	  of	  adolescents	  who	  
reported	  insomnia	  symptoms	  at	  baseline	  continued	  to	  exhibit	  insomnia	  at	  4-­‐y	  follow-­‐up.11	  A	  similar	  
pattern	  of	  symptom	  persistence	  was	  observed	  over	  the	  course	  of	  2	  y	  between	  the	  ages	  of	  13	  to	  15	  
y.12	  Studies	  of	  younger	  children,	  however,	  find	  little	  degree	  of	  persistence	  of	  insomnia	  symptoms,13,	  
14	  although	  one	  study	  demonstrated	  that	  approximately	  60%	  of	  children	  between	  the	  ages	  of	  9	  and	  
11	   y	   reported	   persistent	   difficulties	   initiating	   sleep	   over	   1	   y.5	   Studies	   spanning	   childhood	   and	  
adolescence	  are	  also	  mixed.	  Over	  the	  course	  of	  5	  y,	  Strauch	  and	  colleagues	  reported	  some	  degree	  of	  
stability	  of	   insomnia	  symptoms	  from	  age	  10	  to	  14	  y,15	  although	  only	  2%	  exhibited	  symptoms	  at	  all	  
time	   points.	   Likewise,	   Gregory	   and	   colleagues	   observed	   some	   stability	   of	   sleep	   disturbance	   in	  
children	  aged	  4	  y	  who	  were	  followed	  up	  in	  midadolescence	  (r	  =	  0.29),	  although	  sleep	  disturbances	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largely	   decreased	   over	   time.16	   One	   source	   of	   the	   inconsistencies	   in	   persistence	   rates	   may	   be	  
differences	   in	   mode	   of	   assessment	   (i.e.	   parent	   report	   versus	   child	   report).	   Regardless	   of	   these	  
inconsistencies,	   it	   is	   unequivocal	   that	   sleep	   disturbances	   in	   early	   childhood	   and	   adolescence	  may	  
have	  detrimental	  effects	  on	  brain	  development,	  and	  long-­‐term	  physical	  and	  mental	  health,	  given	  the	  
role	  of	  sleep	  in	  synaptic	  homeostasis,17	  brain	  plasticity,18	  brain	  maturation,19	  and	  immune	  function.20	  
For	   these	   reasons,	   it	   is	   important	   to	  understand	   factors	   contributing	   to	   insomnia	  and	   its	  potential	  
persistence	  over	  time	  in	  early	  childhood	  and	  adolescence.	  	  
Accumulating	   evidence	   from	   large-­‐scale	   twin	   datasets	   points	   to	   the	   possibility	   that,	   in	   adults,	  
insomnia	   is	   to	  some	  extent	  heritable,	  with	  genetic	   factors	  accounting	  for	  approximately	  30-­‐60%	  of	  
variability.21	   Twin	   studies	   in	   early	   childhood	   and	   adolescence,	   however,	   have	   largely	   focused	   on	  
broadly	  defined	  sleep	  disturbances	  rather	  than	  specifically	  investigating	  the	  heritability	  of	  insomnia	  
per	   se.	   For	   example,	   Van	   den	   Oord	   and	   colleagues	   estimated	   that	   genetic	   influences	   contributed	  
approximately	  60%	  of	  variance	  in	  sleep	  disturbances	  assessed	  by	  the	  Child	  Behavior	  Checklist	  (CBCL)	  
in	  3-­‐y-­‐old	  twins.22	  Gregory	  and	  colleagues	  have	  repeatedly	  demonstrated	  the	  heritability	  of	  broadly	  
defined	  sleep	  disturbances	  in	  early	  childhood,	  ranging	  from	  18-­‐20%	  in	  3-­‐	  to	  4-­‐y-­‐old	  twins,23	  to	  ~60-­‐
70%	   at	   8-­‐10	   y	   of	   age.24–26	   Studies	   of	   adolescents	   report	   heritability	   estimates	  more	   akin	   to	   adult	  
estimates.27–30	  	  
Although	  these	  studies	  identify	  the	  presence	  of	  genetic	  factors	  on	  sleep	  disturbances	  during	  discrete	  
time	  points,	   they	   tell	  us	   little	  about	   its	  developmental	   course.	   Longitudinal	  genetically	   informative	  
designs	  allow	  us	  to	  examine	  the	  extent	  to	  which	  genetic	  and	  environmental	  factors	  contribute	  to	  the	  
associations	   in	   a	   phenotype	   over	   time,	   as	   well	   as	   examining	   the	   extent	   of	   stability	   (overlap)	   and	  
change	   in	   the	   contribution	   of	   such	   influences.	   Using	   such	   methodology,	   Gregory	   and	   colleagues	  
reported	  that	  the	  association	  between	  sleep	  disturbances	  at	  8	  and	  10	  y	  of	  age	  share	  some	  genetic	  
overlap	  (46%	  shared	  genetic	  effects).26	  Although	  this	  suggests	  some	  degree	  of	  stability	  in	  the	  genetic	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influences	  on	  sleep	  disturbances	  in	  this	  age	  group,	  it	  also	  suggests	  that	  new	  genetic	  influences	  come	  
into	  play	  at	  10	  y.	  	  
Longitudinal	   twin	   studies	   mapping	   the	   developmental	   course	   of	   insomnia	   from	   early	   childhood	  
through	   adolescence	   are	   lacking.	   Because	   of	   this,	   the	   question	   of	   whether	   genetic	   and	  
environmental	   factors	   contributing	   to	   insomnia	   in	   early	   childhood	   and	   adolescence	   remain	   stable	  
over	  time,	  or	  whether	  new	  etiological	  factors	  come	  into	  play	  during	  this	  period,	  remains	  unknown.	  It	  
is	  possible	  that	  specific	  genes	  contribute	  to	  the	  initial	  onset	  of	  insomnia.	  However,	  it	  is	  also	  possible	  
that	  different	  genes	  are	  partially	  responsible	  for	  its	  maintenance,	  given	  the	  many	  physiological	  and	  
social	  changes	  that	  occur	  from	  the	  transition	  from	  early	  childhood	  to	  adolescence	  through	  puberty,	  
including	  changes	   in	   the	  organization	  of	   the	  circadian	  system,	  as	  well	  as	   sleep	   timing,	  quality,	  and	  
architecture.1	   Moreover,	   pubertal	   development	   has	   been	   associated	   with	   increases	   in	   sleep	  
disturbances,31	   making	   it	   likely	   that	   genetic	   factors	   controlling	   puberty	   contribute	   to	   sleep	  
disturbances	  occurring	  during	  this	  developmental	  age.	  Examining	  the	  extent	  of	  stability	  and	  change	  
in	  the	  genetic	  and	  environmental	  influences	  on	  insomnia	  over	  time	  will	  allow	  us	  to	  further	  progress	  
toward	   identifying	  specific	  genetic	  mechanisms	  underlying	   insomnia.	   In	  addition,	  such	  examination	  
will	   enable	   us	   to	   identify	   specific	   environmental	   factors	   contributing	   to	   insomnia,	   given	   that	   they	  
may	  be	  time	  specific.	  
With	   these	   considerations	   in	   mind,	   the	   objectives	   of	   the	   current	   study	   are	   to	   determine	   the	  
prevalence	  and	  heritability	  of	  insomnia	  symptoms,	  including	  difficulties	  initiating	  sleep,	  maintaining	  
sleep	   and	   early	  morning	   awakenings,	   across	   four	   time	   points	   spanning	   the	   period	   of	   middle/late	  
childhood	   to	   adolescence	   in	   a	   longitudinal	   sequential	   sample	   of	   twins	   aged	   8-­‐18	   y.	   Further,	   this	  
study	   will	   examine	   the	   longitudinal	   associations	   in	   insomnia	   over	   time,	   and	   assess	   the	   extent	   to	  
which	  genetic	  and	  environmental	  factors	  on	  insomnia	  remain	  stable,	  or	  whether	  new	  factors	  come	  





	  The	   data	   for	   this	   study	   are	   derived	   from	   the	   Virginia	   Twin	   Study	   of	   Adolescent	   Behavioral	  
Development	   (VTSABD),	   a	   longitudinal	   sequential	   cohort	   of	   8-­‐	   to	   17-­‐y-­‐old	   Caucasian	   twins	   born	  
between	   1974-­‐1983	   focused	   on	   developmental	   trajectories	   of	   adolescent	   psychopathology	   and	  
associated	  risk	  factors,32,	  33	  as	  well	  as	  the	  Young	  Adult	  Follow-­‐Up	  (YAFU)	  study,34	  of	  the	  same	  twins	  
when	   they	   were	   18	   y	   of	   age.	   Twin	   pairs	   were	   identified	   through	   the	   state	   school	   system	   and	  
participating	  private	  schools	  in	  the	  state	  of	  Virginia	  in	  1989-­‐1990	  and	  were	  then	  contacted	  by	  mail.	  
Interested	   families	   were	   scheduled	   for	   detailed	   assessments	   of	   behavioral	   development	   and	  
psychopathology,	   and	   were	   invited	   to	   participate	   in	   up	   to	   two	   comprehensive	   interview-­‐based	  
follow-­‐up	  assessments.	  At	  wave	  1,	  1,412	  twin	  families	  participated	  (2,822	  individual	  twins	  aged	  8-­‐18	  
y).	   At	   wave	   2,	   which	   took	   place	   on	   average	   1.52	   y	   following	   wave	   1,	   1,047	   families	   participated	  
whose	   children	   continued	   to	   meet	   age	   and	   residence	   requirements	   for	   the	   study	   (80%	   of	   those	  
targeted).	   At	   wave	   3,	   which	   took	   place	   on	   average	   3.3	   years	   following	   wave	   2,	   628	   families	  
participated	   (81%	   of	   those	   targeted).	   All	   twins	   who	   participated	   at	   wave	   1	   were	   recontacted	   as	  
young	  adults	  (when	  aged	  18	  y	  or	  older)	  to	  participate	  in	  a	  telephone	  interview	  as	  part	  of	  the	  YAFU	  
study	  (termed	  wave	  4	  in	  the	  current	  analyses).	  Wave	  4	  took	  place	  over	  a	  variable	  number	  of	  years	  
from	  the	  study’s	  conception	  as	  participants	  were	  contacted	  when	  they	  reached	  18	  y	  of	  age.	  At	  wave	  
4,	   1,185	   twin	   families	   participated	   (84%	   of	   those	   targeted).	   Twenty-­‐four	   percent	   of	   those	   who	  
participated	  in	  the	  YAFU	  participated	  in	  only	  the	  first	  wave	  of	  the	  VTSABD,	  32%	  participated	  in	  two	  
waves,	  31%	  in	  three	  waves,	  and	  13%	  in	  all	  four	  waves.35	  Participating	  families	  were	  representative	  of	  
the	  Virginia	  population	   in	   terms	  of	   socioeconomic	   status.36	  More	  details	  of	   sample	  ascertainment,	  
participation	  rates,	  ages	  of	  assessment,	  and	  socioeconomic	  bias	  for	  the	  four	  waves	  of	  the	  study	  have	  
been	   reported	   elsewhere.32,	   35–37	   Because	   this	   is	   a	   sequential	   longitudinal	   cohort	   that	   contains	  
individuals	   spanning	   the	   ages	   of	   8	   to	   18	   y	   at	   all	   waves,	   results	   are	   interpreted	   in	   terms	   of	   the	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progression	  across	  time,	  rather	  than	  differences	  between	  discrete	  age	  groups.	  Every	  family	  provided	  
signed	  consent	  forms,	  which	  were	  completed	  by	  parents	  when	  twins	  were	  younger	  than	  14	  y,	  and	  by	  
the	   twins	   themselves	  when	   aged	   14	   y	   or	   older.	   Ethical	   approval	   was	   granted	   by	   the	   Institutional	  
Review	  Board	  at	  Virginia	  Commonwealth	  University,	  consistent	  with	  US	  federal	  guidelines.	  
	  
Measures	  
Child	   and	  Adolescent	   Psychiatric	   Assessment:	   Insomnia	   symptoms	  were	   assessed	  by	   the	  Child	   and	  
Adolescent	  Psychiatric	  Assessment	  (CAPA),	  a	  semistructured	  interview	  designed	  to	  assess	  a	  number	  
of	  behavioral	  and	  psychological	  symptoms	  based	  on	  the	  Diagnostic	  and	  Statistical	  Manual	  of	  Mental	  
Disorders	   (DSM)-­‐III-­‐R,38	   as	   this	   was	   the	   current	   diagnostic	   manual	   in	   use	   at	   the	   time	   of	   data	  
collection.	   The	  modules	   for	   sleep	   problems	   by	   child/adolescent	   report	  were	   used	   for	   the	   current	  
analyses.	  	  The	  DSM-­‐III-­‐R	  criteria	  for	  insomnia	  vary	  to	  some	  extent	  to	  the	  current	  criteria	  for	  insomnia	  
disorder	   set	   forth	   in	   DSM-­‐V,9	   and	   consist	   of	   (1)	   difficulty	   initiating	   or	   maintaining	   sleep,	   or	  
nonrestorative	  sleep;	  (2)	  sleep	  difficulty	  that	  occurs	  three	  or	  more	  times	  per	  week	  for	  at	  least	  1	  mo,	  
and	  (3)	  clinically	  significant	  distress	  or	  impairment.	  The	  sleep	  module	  of	  the	  CAPA	  interview	  taps	  into	  
these	  criteria,	  although	  it	  is	  more	  aligned	  to	  DSM-­‐V	  in	  terms	  of	  duration	  (i.e.,	  it	  focuses	  on	  a	  period	  
of	  3	  mo),	   and	   includes	  a	   series	  of	  questions	  about	   the	   child’s/adolescent’s	   current	   sleep	  patterns,	  
including	  whether	  the	  child	  has	  difficulty	   falling	  asleep	  or	  waking	  up	  too	  early	   in	  the	  morning,	  and	  
then	   makes	   a	   clinical	   judgment	   of	   whether	   or	   not	   ‘clinically	   significant	   insomnia’	   symptoms	   are	  
present.	  In	  each	  area,	  the	  presence	  of	  symptoms	  over	  the	  past	  3	  mo	  was	  ascertained,	  along	  with	  the	  
frequency	   of	   occurrence,	   duration,	   and	   earliest	   age	   of	   onset	   (if	   symptoms	   were	   present).	   For	   all	  
questions,	  a	  rating	  of	  0	  was	  used	  if	  it	  was	  determined	  that	  a	  disorder	  was	  not	  present.	  A	  rating	  of	  2	  
indicated	   that	   the	  disorder	  was	  present	   at	   least	   at	   the	  minimum	   level	  of	   severity	   (if	   the	   insomnia	  
covers	  a	  period	  between	  1	  and	  2	  h),	  and	  a	  rating	  of	  3	  that	  the	  disorder	  was	  present	  at	  a	  higher	  level	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of	  severity	  (if	   the	   insomnia	  duration	  was	  greater	  than	  or	  equal	  to	  2	  h	  per	  night).	  A	  rating	  of	  1	  was	  
discouraged	   because	   it	   indicated	   that	   the	   rater	  was	   not	   able	   to	   determine	  whether	   criteria	  were	  
met,	   in	   which	   case	   the	   rater	   was	   supposed	   to	   continue	   to	   query	   the	   respondent	   until	   a	  
determination	   could	   be	  made.	   For	   these	   analyses,	   ratings	   of	   2	   and	   3	  were	   combined	   to	   create	   a	  
dichotomous	  (yes/no)	  insomnia	  rating,	  henceforth	  referred	  to	  as	  ‘clinically	  significant	  insomnia’.	  For	  
descriptive	   purposes,	   additional	   ratings	   of	   the	   timing	   of	   insomnia	   during	   the	   night	   (difficulty	  
initiating	   sleep	   [initial	   insomnia],	   difficulty	   maintaining	   sleep	   [middle	   insomnia],	   or	   early	   morning	  
awakening	   [late	   insomnia]),	   and	   the	   presence	   of	   any	   insomnia	   symptom	   were	   examined	   in	   the	  
current	  analyses.	  These	  ratings	  were	  repeated	  within	  the	  same	  sample	  at	   four	  time	  points	  (waves)	  
from	  age	  8-­‐18	  y	  (only	  participants	  aged	  18	  y	  or	  younger	  were	  retained	  in	  the	  study	  at	  each	  wave).	  
Zygosity:	  Zygosity	  was	  inferred	  using	  an	  algorithm	  that	  incorporates	  data	  from	  parental	  responses	  to	  
a	  questionnaire	  and	   ratings	  of	  photographs,	  and	  validated	   in	  a	   subset	  of	  231	   twin	  pairs	   for	  whom	  
zygosity	  was	  confirmed	  by	  blood	  group	  typing	  or	  DNA	  polymorphisms.	  Additional	  details	  of	  zygosity	  
determination	  in	  this	  sample	  have	  been	  published	  previously.30,	  32	  	  
Data	   Analyses:	  Descriptive	   statistics	   and	   tetrachoric	   correlations	   between	  waves	  were	   computed.	  
Significant	  differences	  in	  the	  proportion	  of	  dichotomous	  insomnia	  symptom	  variables	  across	  waves	  
were	   tested	   using	   χ2	   tests.	   Similarly,	   significant	   differences	   between	   males	   and	   females	   on	  
dichotomous	   insomnia	   symptom	   variables	  were	   tested	   using	   χ2	   tests.	   Differences	   in	   age	   between	  
cases	  of	  insomnia	  symptoms	  versus	  no	  symptoms	  at	  each	  wave	  were	  computed	  using	  t-­‐tests.	  Twin	  
model	  fitting	  was	  performed	  in	  Mx	  (computer	  software	  designed	  to	  analyse	  genetically	  informative	  
designs)	  using	  structural	  equation	  modeling	  and	  the	  method	  of	  maximum	  likelihood	  estimation,39	  on	  
‘clinically	  significant	  insomnia’.	  Twin	  studies	  allow	  us	  to	  estimate	  the	  relative	  contribution	  of	  genetic	  
and	   environmental	   influences	   upon	   traits	   by	   comparing	   the	   similarity	   between	  monozygotic	   (MZ)	  
twins,	   who	   share	   almost	   100%	   of	   their	   genetic	   material,	   and	   dizygotic	   (DZ)	   twins,	   who	   share	   on	  
average	  50%	  of	  their	  segregating	  genes.	  Using	  this	  information	  it	  is	  possible	  to	  parse	  the	  variance	  in	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a	   phenotype	   into	   additive	   genetic	   influences	   (A),	   dominant	   (nonadditive/	   interactive)	   genetic	  
influences	   (D),	   shared/common	   environmental	   influences	   (C)	   (which	   act	   so	   as	   to	   make	   family	  
members	   more	   similar),	   and	   nonshared	   environmental	   influences	   (E)	   (unique	   environmental	  
influences	  that	  contribute	  to	  dissimilarity	  between	  family	  members).27	  It	  is	  not	  possible	  to	  examine	  D	  
and	  C	  simultaneously	  because	  they	  predict	  different	  MZ:DZ	  correlation	  ratios,	  which	  are	  confounded	  
if	   examined	   together.40	  Accordingly,	   it	   is	   typical	   to	   examine	   separate	  ACE	   and	  ADE	  models	   if	   data	  
suggest	  that	  nonadditive	  genetic	  effects	  may	  be	  likely.	  Nonadditive	  genetic	  effects	  are	  implied	  if	  MZ	  
twin	  correlations	  are	  greater	  than	  double	  DZ	  twin	  correlations.	  	  	  
Because	   of	   the	   categorical	   nature	   of	   the	   variables,	   liability	   threshold	   models	   were	   used,	   which	  
assume	  an	  underlying	  normal	   distribution	   to	   the	   categories,	  with	   thresholds	   that	   discriminate	   the	  
classes	   (0,	   1),	   estimated	   from	   the	   relative	   cell	   proportions	   of	   the	  data.	   Initially,	   univariate	  models	  
were	   run	   to	   investigate	   the	   relative	   contribution	   of	   genetic	   and	   environmental	   influences	   on	  
‘clinically	  significant	  insomnia’	  at	  each	  wave.	  The	  fit	  statistic	  provided	  by	  Mx	  for	  raw	  data	  modeling	  is	  
−2LL	  (minus	  twice	  the	  log	  likelihood	  of	  the	  observations).	  Saturated	  models,	  which	  provide	  a	  perfect	  
fit	  to	  the	  data,	  were	  first	  approximated	  to	  the	  data,	  and	  the	  resulting	  -­‐2LL	  was	  then	  subtracted	  from	  
the	   -­‐2LL	   of	   the	   genetic	   models.	   The	   difference	   between	   the	   -­‐2LL	   for	   the	   saturated	   and	   genetic	  
models	  is	  χ2	  distributed	  with	  equal	  df	  and	  so	  provides	  a	  relative	  fit	  index.	  A	  nonsignificant	  difference	  
in	   fit	  between	   the	  genetic	  and	  saturated	  models	   indicates	   that	   the	  genetic	  model	  does	  not	   fit	   the	  
data	   significantly	  worse	   than	   the	   saturated	  model,	   thus	   providing	   a	   good	   description	   of	   the	   data.	  
Akaike’s	   Information	  Criterion	  (AIC)	  also	  provides	  information	  regarding	  fit	  (calculated	  as	  Δχ2	  –	  2	  ×	  
Δdf),	  which	  accounts	  for	  the	  number	  of	  parameters	  being	  estimated	  and	  the	  goodness-­‐of-­‐fit.	  A	  good	  
fit	   is	   indicated	   by	   lower,	   negative	   values	   of	   AIC.41	   Both	   ACE	   and	   ADE	  models	   were	   tested	   as	   the	  
pattern	   of	   twin	   correlations	   suggested	   possible	   nonadditive	   genetic	   effects,	   followed	   by	   more	  
restricted	  models	  where	  one	  of	  the	  parameters	  was	  removed	  (i.e.	  the	  AE,	  DE,	  and	  CE	  models	  were	  
run),	  and	  compared	  to	  the	  fuller	  models	  to	  determine	  their	  significance.	  For	  the	  best-­‐fitting	  models	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(those	   that	   were	   the	   most	   parsimonious,	   that	   did	   not	   significantly	   deviate	   from	   the	   fit	   of	   the	  
saturated	  model),	  likelihood-­‐based	  95%	  confidence	  intervals	  (CIs)	  on	  the	  parameter	  estimates	  were	  
obtained	  in	  order	  to	  determine	  their	  precision.	  	  
Following	   the	   univariate	   analyses,	   multivariate	   Cholesky	   genetic	   models40	   were	   used	   to	   model	  
‘clinically	   significant	   insomnia’	   at	   all	   four	   waves	   simultaneously.	   This	   model	   allows	   us	   to	   test	   the	  
etiological	  specificity	  across	  the	  four	  waves.	  This	  model	  decomposes	  the	  variances	  and	  covariances	  
between	  the	  phenotypes	  into	  latent	  common	  (shared	  between	  the	  phenotypes)	  and	  unique	  (specific	  
to	   each	  phenotype)	   genetic	   and	  environmental	   components	   (see	   Figure	  1	   for	   an	   example	  of	   a	  DE	  
model	  –	  A	  was	  dropped	   for	  simplicity	  of	  presentation).	  This	  model	  provides	  us	  with	   four	  pieces	  of	  
information.	   First,	   it	   indicates	   the	   genetic	   and	   environmental	   influences	   common	   to	   ‘clinically	  
significant	  insomnia’	  at	  all	  four	  waves	  (D1,	  E1).	  Second,	  it	  indicates	  whether	  a	  second	  set	  of	  genetic	  
and	   environmental	   influences	   come	   into	   play	   that	   are	   common	   to	   the	   second,	   third,	   and	   fourth	  
waves	   (D2,	   E2).	   Third,	   it	   indicates	  whether	   a	   third	   set	   of	   influences	   are	   common	   to	   the	   third	   and	  
fourth	  waves	  (D3,	  E3).	  Finally	  it	  indicates	  whether	  a	  unique	  set	  of	  influences	  contribute	  to	  the	  fourth	  
wave	  (D4,	  E4).	   In	  all	  cases,	  the	  model	  allows	  the	  estimation	  of	  unique	  genetic	  factors,	   indicated	  by	  
the	   significance	  of	   the	   diagonal	   elements	   (e.g.	   d11,	   d22,	   d33,	   d44).	   	   If	   there	   are	   common	  genetic	  
factors	  influencing	  more	  than	  one	  wave,	  the	  off-­‐diagonal	  parameter	  estimates	  would	  be	  significantly	  
distinguishable	   from	   zero	   (e.g.,	   d21,	   d31,	   d41,	   d32,	   etc.).	   	   The	   same	   logic	   applies	   to	   the	  
environmental	  factors.	  Each	  of	  the	  parameter	  estimates	  can	  be	  squared	  to	  estimate	  the	  proportion	  
of	   the	  variance	  at	  each	  wave	  accounted	  for	  by	  the	  genetic	  and	  environmental	   factors.	  As	  with	  the	  
univariate	   analyses,	   the	   fit	   of	   the	   full	   model	   was	   compared	   to	   more	   restricted	   models	   that	  
sequentially	  dropped	   individual	  parameter	  estimates.	  Both	  ACE	  and	  ADE	  models	  were	   tested.	   The	  
most	  parsimonious	  model	  that	  did	  not	  fit	  significantly	  worse	  than	  the	  saturated	  model	  was	  selected	  
for	   interpretation.	   Sex	   differences	   in	   the	   etiological	   influences	   in	   both	   univariate	   and	  multivariate	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models	  were	  not	  computed	  given	  the	  small	  cell	  sizes	  by	  sex/zygosity	  group	  for	  later	  waves	  (see	  Table	  
2).	  The	  analyses	  are	  performed	  on	  raw	  data.	  
Results	  
Descriptives	  
	  A	  total	  of	  1,412	  complete	   twin	  pairs	  participated	   in	   the	  study	  at	  wave	  1.	  Overall,	   there	  were	  46%	  
males	   and	  54%	   females	   at	  wave	  1.	   Zygosity	  was	   available	   from	  1,411	   twin	  pairs.	   The	   sex/zygosity	  
groups	  for	  the	  twin	  pairs	  were	  as	  follows:	  322	  MZ	  male	  (MZM),	  417	  MZ	  females	  (MZF),	  180	  DZ	  males	  
(DZM),	  194	  DZ	  females	  (DZF),	  and	  298	  DZ	  opposite	  sex	  pairs	  (DZO).	  The	  modal	  ages	  at	  the	  different	  
waves	  were	   as	   follows:	   8.3	   y	   (range,	   8-­‐18	   y)	   at	   wave	   1;	   10.7	   y	   (range,	   9-­‐18	   y)	   at	   wave	   2;	   14.2	   y	  
(range,	  12-­‐18	  y)	  at	  wave	  3;	  and	  15.3	  y	  (range,	  14-­‐18	  years)	  at	  wave	  4.	  Age	  spread	  at	  each	  wave	  was	  
largely	  homogenously	  distributed	  (e.g.,	  although	  age	  8.3	  y	  was	  most	  common	  at	  wave	  1,	  there	  was	  a	  
relatively	   similar	  distribution	  of	  other	  ages	  within	   this	  wave).	  Complete	  data	  on	  all	   sleep	  variables	  
were	   available	   from	  2,789	   individuals	   at	  wave	  1	   (98.8%	  of	   those	   targeted);	   1,981	   (94.6%	  of	   those	  
targeted)	  at	  wave	  2;	  1,142	  (90.9%	  of	  those	  targeted)	  at	  wave	  3;	  and	  357	  (15.1%	  of	  those	  targeted)	  at	  
wave	   4.	   In	   total,	   325	   individuals	   provided	   complete	   sleep	   data	   at	   all	   four	   waves.	   There	   did	   not	  
appear	  to	  be	  significant	  differences	  in	  insomnia	  ratings	  at	  wave	  1	  among	  those	  who	  did	  and	  did	  not	  
participate	   at	   all	   four	  waves	   (χ2[1]	   =	   0.15,	   P	   =	   0.70),	   indicating	   no	   evidence	   of	   selective	   attrition.	  
Retrospective	   reports	   from	  parents	   indicated	   that	  MZ	   twins	  were	   significantly	  more	   likely	   than	  DZ	  
twins	  to	  share	  a	  bedroom	  with	  their	  co-­‐twin	  in	  young	  childhood	  (99%	  of	  MZ	  twins	  shared	  a	  bedroom	  
always,	  usually	  or	   sometimes;	  compared	   to	  94%	  of	  DZs:	  χ2[3]	  =	  143.66,	  P	  =	  0.00)	  as	  well	  as	  at	   the	  
time	   of	   initial	   assessment	   (64%	   of	   MZ	   twins	   shared	   a	   bedroom	   always,	   usually,	   or	   sometimes;	  
compared	  to	  35%	  of	  DZs:	  χ2[3]	  =	  117.61,	  P	  =	  0.00).	  Whether	  or	  not	  twins	  shared	  a	  bedroom	  did	  not	  
reliably	   contribute	   to	   twin	   similarity	   on	   our	   measure	   of	   clinically	   significant	   insomnia	   (analyses	  
available	  upon	  request	  from	  the	  first	  author).	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Frequency	  of	   insomnia	  symptoms	  for	  the	  total	  sample	  and	  categorized	  by	  sex	   is	  shown	   in	  Table	  1.	  
The	  proportion	  of	  individuals	  meeting	  criteria	  for	  a	  rating	  of	  ‘clinically	  significant	  insomnia’	  based	  on	  
child/adolescent	  ratings	  significantly	  decreased	  across	  all	  waves,	  from	  19.5%	  at	  wave	  1	  to	  11.5%	  at	  
wave	  4	  (overall:	  χ2[3]	  =	  14.58,	  P	  =	  0.00;	  all	  χ2’s	   individually	  comparing	  waves	  1-­‐3	  versus	  wave	  4:	  P	  <	  
0.05).	  Significance	  of	  the	  decrease	  in	  the	  proportion	  of	  individual	  insomnia	  symptoms	  across	  waves	  
is	  shown	  in	  Table	  1.	  
At	  wave	  2,	  there	  were	  significant	  sex	  differences	  in	  ratings	  of	  ‘clinically	  significant	  insomnia’	  (χ2[1]	  =	  
4.43,	  P	  =	  0.04),	  middle	  insomnia	  (χ2[1]	  =	  5.54,	  P	  =	  0.02),	  and	  the	  presence	  of	  any	  insomnia	  symptom	  
(χ2[1]	   =	   6.06,	   P	   =	   0.02).	   At	   wave	   3,	   there	   were	   significant	   sex	   differences	   in	   ratings	   of	   ‘clinically	  
significant	   insomnia’	   (χ2[1]	   =	   5.15,	   P	   =	   0.02),	  middle	   insomnia	   (χ2[1]	   =	   11.71,	   P	   =	   0.001),	   and	   the	  
presence	  of	   any	   insomnia	   symptom	   (χ2[1]	   =	   9.61,	   P	  =	  0.00).	  At	  wave	  4,	   there	  were	   significant	   sex	  
differences	   in	  ratings	  of	   ‘clinically	  significant	   insomnia’	   (χ2[1]	  =	  4.07,	  P	  =	  0.05),	  and	   initial	   insomnia	  
(χ2[1]	  =	  6.44,	  P	  =	  0.02).	  In	  all	  cases,	  insomnia	  symptoms	  were	  more	  prevalent	  in	  females	  than	  males.	  
There	  were	  no	  other	  significant	  sex	  differences	  in	  insomnia	  variables	  at	  all	  waves.	  	  
At	  wave	  1	  there	  were	  significant	  age	  differences	  in	  the	  presence	  of	  middle	  insomnia	  (t[2792]	  =	  3.82,	  
P	   =	   0.00).	   At	   wave	   2	   there	   were	   significant	   age	   differences	   in	   the	   presence	   of	   middle	   insomnia	  
(t[1984]	  =	  2.53,	  P	  =	  0.01)	  and	  any	  insomnia	  symptom	  (t[1984]	  =	  2.38,	  P	  =	  0.02).	  At	  wave	  3	  there	  were	  
significant	  age	  differences	  in	  the	  presence	  of	  middle	  insomnia	  (t[1135]	  =	  2.46,	  P	  =	  0.01).	  In	  all	  cases,	  
younger	   children	   were	   more	   likely	   than	   older	   children	   to	   experience	   insomnia	   symptoms	   at	   the	  
same	  wave.	  	  
Insert	  Table	  1	  here	  
Frequency	   of	   cases	   (individuals	   categorized	   as	   ‘yes’	   for	   ratings	   of	   ‘clinically	   significant	   insomnia’	  
present)	  split	  by	  sex	  and	  zygosity	  is	  shown	  in	  Table	  2.	  Because	  of	  the	  small	  number	  of	  cases	  in	  each	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sex/zygosity	   group	  at	  each	  wave,	   it	  was	  not	  possible	   to	  perform	  genetic	  model	   fitting	  analyses	  by	  
sex.	  As	  such,	  genetic	  model	  fitting	  analyses	  are	  performed	  for	  the	  total	  sample	  only.	  
Insert	  Table	  2	  here	  
Twin	  Correlations	  
	  Twin	  correlations	  for	  ratings	  of	  ‘clinically	  significant	  insomnia’	  at	  different	  waves	  are	  shown	  in	  Table	  
3a.	   MZ	   twin	   correlations	   were	   greater	   than	   corresponding	   DZ	   twin	   correlations	   for	   ‘clinically	  
significant	   insomnia’	  at	  all	  waves,	   suggesting	   the	   influence	  of	  genetics	  on	   this	  phenotype.	  Because	  
the	  MZ	   twin	   correlations	  were	   greater	   than	   double	   the	   DZ	   twin	   correlations,	   nonadditive	   genetic	  
effects	  were	  implied	  and	  so	  ADE	  model	  fitting	  analyses	  were	  performed	  in	  addition	  to	  ACE	  models.	  	  
Phenotypic	  Correlations:	  Tetrachoric	  correlations	  for	  ratings	  of	  ‘clinically	  significant	  insomnia’	  across	  
waves	  are	   shown	   in	  Table	  3b.	   There	  were	   significant	   associations	  between	   insomnia	   symptoms	  at	  
adjacent	  waves	   (wave	  1	  with	  2;	  wave	  2	  with	  3;	  and	  wave	  3	  with	  4)	  but	  not	  at	  nonadjacent	  waves	  
(e.g.,	  wave	  1	  with	  wave	  3	  or	  4).	  
Cross-­‐Twin	  Cross-­‐Trait	  Correlations:	  Cross-­‐twin	  cross-­‐trait	  correlations	  (shown	  in	  Table	  3c)	  were	  only	  
significant	   for	   MZ	   twins	   on	   the	   association	   between	   ratings	   of	   ‘clinically	   significant	   insomnia’	   at	  
waves	   1	   and	   2.	   Despite	   the	   nonsignificance	   of	   the	   other	   associations,	   in	   all	   cases	   MZ	   twin	  
correlations	  were	  greater	  than	  DZ	  correlations,	  suggesting	  possible	  genetic	  effects	  on	  the	  cross-­‐wave	  
associations.	  	  
Insert	  Table	  3	  here	  
Univariate	  Genetic	  Model	  Fitting	  Analyses	  
	  Model	  fitting	  analyses	  are	  shown	  in	  Table	  4.	  At	  waves	  1,	  2,	  and	  4,	  the	  best-­‐fitting	  models	  were	  ones	  
in	   which	   additive	   genetic	   influences	   were	   dropped,	   and	   shared	   environmental	   influences	   were	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replaced	  with	  nonadditive	  genetic	  effects	  (DE	  models).	  In	  these	  models,	  nonadditive	  genetic	  effects	  
contributed	   33%[95%	   CI	   .20-­‐.46],	   38%[.22-­‐.78]	   and	   24%[.00-­‐.66]	   of	   the	   total	   variance	   at	   waves	   1,	   2	   and	   4,	  
respectively.	  At	  wave	  3,	   the	  best-­‐fitting	  model	  was	  one	   in	  which	   shared	  environmental	   influences	  
were	   dropped	   (AE	  model).	   In	   this	  model,	   additive	   genetic	   influences	   contributed	   14%[.00-­‐.35]	   of	   the	  
variance	  in	  ratings	  of	  ‘clinically	  significant	  insomnia’.	  At	  all	  waves,	  the	  remaining	  source	  of	  variance	  
was	  the	  nonshared	  environment	  (accounting	  for	  67%[.54-­‐.80],	  62%[.48-­‐.78],	  86%[.65-­‐1.00],	  and	  76%[.34-­‐1.00]	  of	  
variance	  explained	  for	  waves	  1,	  2,	  3,	  and	  4,	  respectively).	  
Insert	  Table	  4	  here	  
Multivariate	  Cholesky	  Model	  Fitting	  Analyses	  
	  For	  the	  fullest	  multivariate	  Cholesky	  models,	  an	  ADE	  model	  provided	  a	  better	  fit	  to	  the	  data	  than	  an	  
ACE	  model	   (as	   indicated	  by	   lower	  AIC).	   In	  addition,	   a	  DE	  model	   including	  all	   four	  Cholesky	   factors	  
provided	  a	  better	  fit	  to	  the	  data	  than	  the	  saturated	  ADE	  model	  (Δ	  χ2(10)	  =	  2.04,	  P	  =	  0.99,	  ΔAIC	  =	  -­‐
17.96).	   Subsequent	   models	   were	   then	   run	   to	   test	   the	   significance	   of	   each	   of	   the	   Cholesky	  
parameters.	  Dropping	  the	  unique	  genetic	  factor	  at	  wave	  4	  did	  not	  result	  in	  a	  significant	  loss	  of	  model	  
fit	  (Δχ2(1)	  =	  0.00,	  P	  =	  1.00,	  ΔAIC	  =	  -­‐2.00).	  Additionally	  dropping	  the	  genetic	  factors	  at	  wave	  3	  (both	  
unique	  and	   shared	  with	  wave	  4)	  did	  not	   result	   in	  a	   significant	   loss	  of	  model	   fit	   (Δχ2(3)	  =	  0.56,	  P	  =	  
0.91,	  ΔAIC	  =	   -­‐5.44).	   Further	  dropping	   the	  genetic	   factors	   at	  wave	  2	   (both	  unique	  and	   shared	  with	  
subsequent	  waves)	  did	  not	  significantly	  reduce	  model	  fit	  (Δ	  χ2(6)	  =	  8.98,	  P	  =	  0.17,	  ΔAIC	  =	  -­‐3.02),	  but	  
examination	  of	  the	  ΔAIC	  value	  indicated	  that	  the	  best-­‐fitting	  model	  was	  the	  previous	  model,	  which	  
allowed	  genetic	  factors	  from	  waves	  1	  and	  2	  to	  map	  onto	  subsequent	  waves.	  Removal	  of	  any	  of	  the	  
nonshared	   environmental	   factors	   significantly	   reduced	   model	   fit	   in	   all	   cases	   (all	   P	   <	   0.05).	  
Standardized	   path	   coefficients	   for	   each	   of	   the	   significant	   paths	   from	   the	   best-­‐fitting	   model	   are	  
shown	  in	  Figure	  1.	  	  	  




This	  set	  of	  analyses	  sought	  to	  determine	  the	  extent	  to	  which	  genetic	  and	  environmental	  influences	  
on	   insomnia	   are	   stable	   across	   childhood	   and	   adolescence.	   Our	   analyses	   focus	   on	   data	   from	   a	  
sequential	  sample	  of	  twins	  followed	  up	  across	  time,	  with	  time	  points	  representative	  of	  children	  and	  
adolescents	  aged	  8,	  10,	  14,	  and	  15	  y	  across	  the	  four	  waves.	  There	  are	  four	  noteworthy	  findings	  from	  
this	   research.	   First,	   prevalence	   of	   ‘clinically	   significant	   insomnia’	   was	   relatively	   high	   compared	   to	  
expected	  figures	  for	  adulthood	  in	  middle/late	  childhood,	  but	  significantly	  decreased	  to	  levels	  in	  line	  
with	   adults	   by	   adolescence.	   Similarly,	   individual	   insomnia	   symptoms	   (initial	   insomnia,	   middle	  
insomnia,	   and	   early	   morning	   awakening)	   significantly	   decreased	   across	   waves.	   This	   decrease	   in	  
insomnia	  symptoms	  by	  adolescence	  is	  consistent	  with	  a	  study	  demonstrating	  a	  decrease	  in	  broadly	  
defined	  sleeping	  difficulties	  in	  children	  age	  4	  y	  though	  adolescence.16	  Another	  study	  documented	  a	  
decrease	   in	   insomnia	   symptoms	   (specifically	   difficulties	   initiating	   sleep)	   from	   age	   10	   to	   13	   y	   in	   a	  
longitudinal	   study	  of	  more	   than	  1,000	  children.42	  The	  current	   study	  extends	   this	  previous	  work	  by	  
demonstrating	   the	   continued	   decrease	   in	   insomnia	   symptoms	   throughout	   adolescence.	   One	  
possibility	  for	  this	  greater	  proportion	  of	  insomnia	  symptoms	  in	  younger	  children	  in	  comparison	  with	  
adolescents	   could	   be	   that	   insomnia	   symptoms	   in	   younger	   children	   may	   be	   largely	   behavioral	   in	  
nature	  (i.e.,	  behavioral	  insomnia	  of	  childhood),	  and	  stem	  from	  poor	  sleep	  hygiene	  and	  inappropriate	  
associations	  of	  the	  bedroom	  environment	  with	  wakefulness	  (i.e.,	  children	  often	  use	  their	  bedrooms	  
for	   play),	   which	   may	   cease	   by	   adolescence.	   Alternatively,	   it	   is	   possible	   that	   as	   parents	   often	   set	  
bedtimes	  in	  younger	  children,	  timing	  of	  sleep	  does	  not	  coincide	  with	  the	  child’s	  feelings	  of	  tiredness	  
or	  their	  optimal	  time	  for	  sleep	  onset	  as	  governed	  by	  that	  child’s	  circadian	  rhythm.	  As	  a	  consequence,	  
the	  child	  may	  lie	  awake,	  unable	  to	  sleep	  for	  periods	  of	  time.	  During	  adolescence,	  parents	  may	  be	  less	  
stringent	   about	   bedtimes,	   allowing	   their	   children	   to	   go	   to	   bed	   at	   times	   more	   in	   line	   with	   their	  
circadian	   rhythm,	   and	  as	   such	  adolescents	  may	  experience	   fewer	   sleep	  difficulties	   if	   they	   attempt	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sleep	  at	  times	  in	  line	  with	  circadian	  rhythmicity.	  The	  decrease	  in	  sleep	  disturbances	  may	  also	  reflect	  
changes	  in	  maturation	  and	  sleep	  architecture,	  which	  occur	  during	  this	  time.43	  
Second,	   there	  were	  associations	  between	   ‘clinically	   significant	   insomnia’	  between	  adjacent	  waves,	  
suggesting	   that	   within	   childhood	   and	   adolescence,	   insomnia	   persists,	   but	   that	   continuity	   of	  
symptoms	   across	   time	  within	   childhood	   and	   adolescence	   is	  minimal.	   This	   is	   also	   reflected	   by	   the	  
smaller	   phenotypic	   correlation	   between	   waves	   2	   and	   3	   (the	   mode	   ages	   of	   which	   span	   these	  
developmental	  time	  periods),	  in	  comparison	  to	  the	  phenotypic	  correlations	  between	  waves	  1	  and	  2;	  
and	  3	  and	  4.	  This,	  again,	  reflects	  the	  possible	  changes	  in	  sleep	  that	  occur	  during	  the	  transition	  from	  
childhood	  to	  adolescence.	  
Third,	  genetic	  factors	  contributed	  to	  ratings	  of	  ‘clinically	  significant	  insomnia’	  at	  all	  waves,	  from	  33%,	  
38%,	   14%,	   and	   24%	   in	   waves	   1,	   2,	   3,	   and	   4,	   respectively.	   The	   genetic	   estimates	   are	   in	   line	   with	  
estimates	  we	  would	  expect	  in	  adults21	  in	  our	  sample	  at	  wave	  1	  and	  wave	  2;	  yet	  are	  somewhat	  lower	  
in	  our	  sample	  at	  later	  waves.	  This	  highlights	  the	  greater	  importance	  of	  the	  nonshared	  environment	  
during	  adolescence	   in	  comparison	  with	  that	   in	  younger	  children,	   in	  whom	  a	  host	  of	  environmental	  
and	   social	   changes	   are	   likely	   to	   take	   place,	   which	   may	   consequently	   interfere	   with	   sleep.	  
Interestingly,	  our	  results	  highlight	  the	  contribution	  of	  nonadditive	  genetic	  effects	  at	  waves	  1,	  2,	  and	  
4,	   providing	   us	   with	   insight	   into	   the	   possible	   genetic	   mechanisms	   at	   play.	   However,	   the	   greater	  
within-­‐pair	  correlations	   in	  MZ	  twins	  compared	  with	  those	  of	  DZ	  twins	  could	  suggest	  an	  alternative	  
explanation.	  Such	  a	  pattern	  of	  results	  could	  suggest	  the	  presence	  of	  sibling	   interaction,	  where	  one	  
twin’s	  behavior	  affects	  that	  of	  the	  co-­‐twin,	  rather	  than	  nonadditive	  genetic	  effects.44,	   45	  This	  seems	  
plausible	  in	  the	  context	  of	  sleep,	  as	  the	  sleep	  behavior	  of	  one	  twin	  may	  similarly	  influence	  that	  of	  the	  
co-­‐twin	  if	  twins	  share	  a	  bedroom.	  Indeed,	   in	  the	  current	  sample,	  MZ	  twins	  were	  significantly	  more	  
likely	  than	  DZ	  twins	  to	  share	  a	  bedroom	  with	  their	  co-­‐twin	  in	  young	  childhood	  as	  well	  as	  at	  the	  time	  
of	  assessment.	  That	  said,	  evidence	  of	  sibling	  interaction	  also	  requires	  greater	  variance	  in	  DZ	  twins	  as	  
in	  comparison	  with	  MZ	  twins	  for	  the	  phenotypes	  of	  interest	  (i.e.,	   insomnia).	   In	  the	  current	  sample,	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variances	   for	   MZ	   twins	   were	   comparable	   to	   those	   for	   DZ	   twins	   at	   each	   wave	   (unreported,	   but	  
available	  upon	  request	  from	  the	  first	  author),	  making	  the	  pattern	  of	  results	  more	  consistent	  with	  an	  
interpretation	  based	  on	  nonadditive	  genetic	  effects	  rather	  than	  sibling	  interaction.	  Although	  there	  is	  
statistical	   support	   for	  a	  nonadditive	   component,	  our	   sample	   size	  has	   limited	  power	   to	   resolve	   the	  
reduction	  in	  DZ	  correlations	  because	  of	  nonadditive	  effects	  from	  that	  caused	  by	  the	  effects	  of	  sibling	  
interaction.	  
Fourth,	  evaluation	  of	   the	  multivariate	  model	   indicated	  that	  genetic	   factors	   influencing	   insomnia	  at	  
wave	  1	   contribute	   to	   the	  maintenance	  of	   insomnia	   through	   adolescence.	   This	   is	   consistent	  with	   a	  
study	  demonstrating	   that	   the	   stability	  of	   sleep	  difficulties	   from	  age	  8	   to	  10	   y	  was	   to	   the	   result	  of	  
shared	   genetic	   effects.26	   Additionally,	   new	   genetic	   influences	   come	   into	   play	   at	   wave	   2,	   which	  
further	  contribute	  to	  the	  maintenance	  of	  insomnia	  through	  adolescence.	  In	  contrast,	  no	  new	  genetic	  
influences	  come	  into	  play	  at	  waves	  3	  and	  4.	  It	  is	  likely	  that	  genes	  controlling	  the	  sleep-­‐wake	  system	  
are	   implicated	   in	   insomnia	   (such	   as	   those	   controlling	   the	   regulation	   of	   the	   sleep-­‐wake	   switch,	  
including	   the	   activity	   of	   acetylcholine,	   glutamate,	   gamma-­‐aminobutyric	   acid	   (GABA),	   and	   the	  
monoamines).	  Indeed,	  molecular	  genetic	  studies	  in	  adults	  have	  demonstrated	  associations	  between	  
several	  of	  such	  genes	  and	  insomnia	  or	  poor	  sleep	  quality,	   including	  the	  serotonin	  transporter	  gene	  
(5HTTLPR),46–49	   monoamine	   oxidase-­‐A,50	   and	   GABA,51	   among	   others.52	   Other	   candidates	   may	   be	  
genes	  implicated	  in	  the	  control	  of	  the	  circadian	  clock.	  Indeed,	  a	  polymorphism	  of	  the	  CLOCK	  3111T/C	  
polymorphism	  has	  been	  associated	  with	   insomnia	   in	  a	  sample	  of	  patients	  with	  major	  depression,53	  
although	   results	   are	   mixed.46,	   54	   However,	   most	   molecular	   genetic	   studies	   focus	   on	   variation	   in	  
normal	   sleep	   characteristics,	   or	   are	   speculative	   studies	   on	   sleep	   phenotypes	   in	  Drosophila,	   rather	  
than	  focusing	  on	  clinically	  significant	  insomnia.	  Although	  this	  handful	  of	  studies	  provide	  clues	  as	  to	  
the	  likely	  genes	  involved,	  further	  studies	  specifically	  focusing	  on	  insomnia	  populations	  are	  required.	  
Furthermore,	   molecular	   genetic	   studies	   in	   childhood	   and	   adolescence	   will	   allow	   us	   to	   determine	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whether	  the	  same	  genetic	  pathways	  are	  involved	  in	  symptoms	  during	  these	  developmental	  periods	  
as	  in	  adulthood.	  	  
The	   stability	   of	   genetic	   effects	   from	  wave	   2	   through	  wave	   4	   implies	   that	   the	   same	   set	   of	   genetic	  
factors	   may	   contribute	   to	   insomnia	   over	   this	   time	   period.	   Studies	   spanning	   adolescence	   and	  
adulthood	  are	  now	  required	  to	  chart	  the	  stability	  of	  genetic	  effects	  over	  longer	  time	  frames.	  This	  will	  
enable	  us	  to	  determine	  whether	  insomnia	  in	  early	  childhood,	  adolescence,	  and	  adulthood	  stem	  from	  
the	  same	  genetic	  pathways,	  and	  whether	  they	  are,	  genetically	  speaking,	  similar	  phenotypes.	  	  
In	  addition	  to	  understanding	  the	  genetic	  mechanisms	  involved,	  the	  current	  study	  allows	  us	  to	  make	  
inferences	   about	   the	   role	   of	   the	   environment.	   In	   univariate	   models,	   nonshared	   environmental	  
influences	  accounted	  for	  the	  majority	  of	  variance	  in	  insomnia.	  In	  the	  multivariate	  model,	  only	  time-­‐
specific	  nonshared	  environmental	  influences	  were	  significant	  (with	  the	  exception	  of	  a	  small	  amount	  
of	  overlapping	  nonshared	  environmental	  factors	  between	  waves	  3	  and	  4),	  suggesting	  little	  overlap	  in	  
the	   environmental	   influences	   contributing	   to	   insomnia.	   This	   finding	   suggests	   that	   environmental	  
factors	  have	  only	  a	  transient	  effect	  on	  sleep,	  rather	  than	  contributing	  to	  sleep	  over	  time.	  This	   is	   in	  
line	  with	  Spielman’s	  ‘3P’	  model	  of	  insomnia,	  which	  proposes	  that	  ‘precipitating’	  factors	  (which	  may	  
include	  environmental	  factors	  such	  as	  stressful	  life	  events)	  act	  as	  a	  trigger	  for	  the	  onset	  of	  insomnia	  
in	  individuals	  with	  a	  predisposition	  to	  insomnia	  (such	  as	  genetic	  vulnerability);	  yet	  the	  maintenance	  
of	   insomnia	   is	   influenced	   by	   distinct	   ‘perpetuating’	   factors	   after	   the	   precipitating	   factor	   has	   been	  
surpassed.55	  	  
Despite	   these	   findings,	   this	   study	   has	   several	   limitations.	   First,	   although	   a	   strength	   of	   this	   study,	  
these	  results	  reflect	  a	  sequential	  longitudinal	  cohort	  that	  contains	  individuals	  spanning	  the	  ages	  of	  8	  
to	   18	   y	   at	   all	   waves;	   therefore,	   the	   results	  must	   be	   interpreted	   in	   terms	   of	   changes	   across	   time,	  
rather	   than	  specifically	   focusing	  on	  discrete	  age	  groups.	  However,	   in	  each	  of	   the	  waves,	  particular	  
ages	  were	  more	  common,	  and	   the	  sample	  mostly	   represents	  children	  and	  adolescents	  aged	  8,	  10,	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14,	  and	  15	  y	  across	  the	  four	  waves.	  Although	  it	  would	  be	  theoretically	  possible	  to	  perform	  analyses	  
based	  on	  discrete	   age	   groups	   irrespective	   of	  wave,	   the	   small	   sample	   size	   in	   the	   latter	   age	   groups	  
would	   provide	   limited	   power	   to	   meaningfully	   report	   on	   age-­‐related	   changes	   in	   the	   etiological	  
influences.	   Second,	   the	   data	   are	   subjective	   in	   nature	   rather	   than	   measures	   of	   objective	   sleep	  
difficulties.	   That	   said,	   insomnia	   is	   considered	   a	   subjective	   complaint,	   as	   clinical	   diagnosis	   is	   based	  
purely	   on	   subjective	  measures,9	   and	   it	   is	   often	   the	   case	   that	   individuals	  with	   insomnia	   exhibit	   no	  
objectively	   recorded	   sleep	   deficit	   despite	   the	   subjective	   dissatisfaction	   with	   sleep	   quality	   or	  
quantity.56	  Accordingly,	  measuring	  insomnia	  by	  subjective	  methods	  appears	  most	  appropriate.	  Third,	  
and	  on	  a	  related	  note,	   it	   is	  possible	  that	  our	   insomnia	  measures	  are	  confounded	  by	  traits	   that	  are	  
typically	  associated	  with	   insomnia,	   such	  as	  depression	  and	  neuroticism.57,	   58	   This	  would	  mean	   that	  
our	  estimates	  of	  heritability,	  rather	  than	  purely	  reflecting	   insomnia,	  may	  to	  some	  extent	  reflect	  an	  
underlying	   mood	   or	   personality	   disorder.	   In	   order	   to	   address	   these	   potential	   confounds,	   we	  
additionally	   examined	   point	   biserial	   correlations	   between	   each	   of	   our	   insomnia	   variables	   and	  
depression	   (measured	   using	   the	   Mood	   and	   Feelings	   Questionnaire	   [MFQ]59)	   and	   neuroticism	  
(measured	  using	   the	  Emotionality,	  Activity,	   Sociability,	   and	   Impulsivity	  Temperament	   Survey [EASI-­‐
III]60)	  at	  waves	  1-­‐3	   (as	  data	   from	  the	  MFQ	  and	  EASI	  were	  only	  available	  at	   theses	  waves;	  analyses	  
available	  upon	  request	  from	  the	  first	  author).	  Although	  all	  of	  these	  correlations	  (with	  the	  exception	  
of	  two)	  were	  significant,	  all	  were	  small	  (ranging	  between	  r	  =	  0.05-­‐0.26),	  suggesting	  minimal	  overlap	  
between	  our	  insomnia	  variables,	  depression,	  and	  neuroticism.	  Accordingly,	  we	  can	  be	  confident	  that	  
our	   estimates	   of	   heritability	   reflect	   sources	   of	   variance	   attributable	   to	   insomnia,	   to	   some	   extent	  
independent	   of	   these	   potential	   confounds	   (we	   acknowledge	   that	   the	   best	  method	   to	   control	   for	  
these	  potential	  confounds	  would	  be	  to	  regress	  out	  the	  effects	  of	  depression/neuroticism	  from	  our	  
insomnia	  variables	  and	  examine	   the	   resulting	   change	   in	  A,	  C,	  and	  E;	  however,	  because	   these	  data	  
were	  available	  only	  from	  waves	  1-­‐3	  of	  the	  study,	  we	  are	  unable	  to	  treat	  the	  data	  equally	  across	  the	  
four	   waves).	   Fourth,	   the	   current	   analyses	   are	   based	   on	   self-­‐report	   responses	   from	   the	   CAPA	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interview	   rather	   than	   parent-­‐reported	   symptoms.	   Although	   the	   accuracy	   of	   self-­‐report	   in	   young	  
children	   could	   be	   questioned,	   one	   study	   demonstrated	   that	   children	   as	   young	   as	   8	   y	   are	   able	   to	  
report	  on	  their	  own	  symptoms.61	  Other	  studies	   in	  young	  children	   largely	   focus	  on	  parent-­‐reported	  
symptoms,	   and	   so	   comparison	   with	   these	   studies	   should	   take	   this	   point	   into	   consideration.	  
However,	   studies	   specifically	   comparing	   parent-­‐	   and	   child-­‐reported	   symptoms	   typically	   find	   that	  
parents	  underestimate	  sleep	  disturbances	  in	  their	  children.62	  Indeed,	  a	  previous	  paper	  reporting	  on	  
insomnia	  symptoms	  from	  wave	  1	  of	  the	  current	  sample	  also	  demonstrate	  this	  pattern.30	  Similarly,	  a	  
study	  comparing	  adolescent-­‐	  and	  parent-­‐reported	  sleep	  patterns	  with	  actigraphy	  over	  the	  course	  of	  
1	  w	  demonstrated	  little	  concordance	  between	  raters.63	  Adolescents	  were	  more	  accurate	  at	  reporting	  
on	  their	  sleep	  than	  were	  their	  parents.	  The	  general	  trend	  for	  parents	  to	  become	  progressively	  more	  
inaccurate	  at	  reporting	  on	  their	  offsprings’	  sleep	   is	   likely	  because	  of	  their	   lack	  of	  awareness	  of	  the	  
childrens’	  nighttime	  behavior.	  The	  current	  analyses	  may	  be	  the	  best	  representation	  of	  the	  sleep	  of	  
these	   individuals.	   Finally,	   the	   small	   sample	   size	   in	   later	   waves	  meant	   that	   it	   was	   not	   possible	   to	  
examine	  sex	  differences	  in	  the	  etiology	  of	  insomnia	  over	  time.	  Given	  that	  insomnia	  is	  typically	  more	  
prevalent	   in	   females64	   (a	   pattern	   that	   was	   also	   mirrored	   in	   the	   current	   data),	   it	   is	   possible	   that	  
different	  mechanisms	   are	   at	   play	   between	   the	   sexes.	   Further	   investigation	   of	   sex	   specific	   genetic	  
effects	  is	  warranted.	  	  	  
In	  conclusion,	  these	  findings	  contribute	  to	  our	  knowledge	  of	  the	  prevalence	  of	  insomnia	  symptoms	  
and	   factors	   influencing	   insomnia	   in	   middle/late	   childhood	   through	   to	   adolescence.	   Insomnia	  
symptoms	  were	  more	  prevalent	  in	  younger	  children,	  decreasing	  to	  estimates	  akin	  to	  those	  typically	  
observed	   in	   adults,	   by	   adolescence.	   ‘Clinically	   significant	   insomnia’	   (as	   rated	   by	   clinicians)	   was	  
moderately	  heritable	  at	  all	  waves,	  and	   is	   in	   line	  with	  heritability	  observed	   in	  adulthood	   in	  younger	  
children,	  but	  somewhat	  lower	  during	  adolescence.	  At	  all	  waves	  the	  remaining	  source	  of	  variance	  was	  
the	   nonshared	   environment,	   with	   no	   influence	   of	   family-­‐wide	   (shared	   environmental)	   factors.	  
Genetic	   influences	  on	   ‘clinically	   significant	   insomnia’	   showed	  a	  substantial	  degree	  of	   stability	   from	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wave	   1	   through	  wave	   4,	  with	   new	   genetic	   factors	   coming	   into	   play	   at	  wave	   2.	  Molecular	   genetic	  
studies	   of	   childhood	   and	   adolescent	   insomnia	   are	   now	   required	   in	   order	   to	   determine	   the	  
mechanism	   through	   which	   insomnia	   manifests	   and	   is	   maintained	   through	   these	   developmental	  
periods.	  Such	  knowledge	  will	  provide	  us	  with	  clues	  as	  to	  biological	  mechanisms	  involved,	  and	  could	  



















Table	  1.	  Prevalence	  of	  child/adolescent	  reported	  insomnia	  symptoms	  (n	  cases	  in	  parentheses)	  
	   Wave	  1	   Wave	  2	   Wave	  3	   Wave	  4	  




































































































For	   these	   analyses,	   ratings	   of	   2	   and	   3	   were	   combined	   and	   compared	   to	   those	   rated	   0	   to	   create	  
dichotomous	  (yes/no)	  insomnia	  ratings.	  Percentages	  reflect	  responses	  of	  ‘yes’	  to	  insomnia	  symptom	  
questions.	  
	  *Significant	  sex	  differences	  in	  proportion	  of	  cases	  (χ2),	  P	  <	  0.05.	  
	  a	  Significant	  differences	  in	  prevalence	  between	  all	  waves	  versus	  wave	  4,	  individually,	  P	  <	  0.05.	  	  
b	  Significant	  difference	  in	  prevalence	  between	  wave	  1	  versus	  wave	  3,	  wave	  2	  versus	  wave	  3,	  wave	  2	  
versus	  wave	  4,	  and	  wave	  3	  versus	  wave	  4;	  individually,	  P	  <	  0.05.	  
	  c	   Significant	   difference	   in	   prevalence	   between	   wave	   1	   versus	   wave	   3,	   wave	   1	   versus	   wave	   4;	  
individually,	  P	  <	  0.05.	  d	  Significant	  difference	  in	  prevalence	  between	  wave	  1	  versus	  wave	  3,	  wave	  1	  
versus	  wave	  4,	  wave	  2	  versus	  wave	  3,	  wave	  2	  versus	  wave	  4,	  and	  wave	  3	  versus	  wave	  4;	  individually,	  




Table	  2.	  Frequencies	  of	  self-­‐reported	  ‘clinically	  significant	  insomnia’	  by	  zygosity	  	  (total	  n	  of	  those	  
with	  and	  without	  insomnia	  in	  parentheses)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   Wave	  1	   Wave	  2	   Wave	  3	   Wave	  4	  
MZM	   118	  (635)	  –	  18.6%	   78	  (483)	  –	  16.1%	   40	  (276)	  –	  14.4%	   8	  (93)	  –	  8.6%	  
DZM	   63	  (356)	  –	  17.7%	   36	  (251)	  –	  14.3%	   26	  (165)	  –	  15.8%	   4	  (46)	  –	  8.7%	  
MZF	   156	  (828)	  –	  18.8%	   122	  (588)	  –	  20.7%	   64	  (340)	  –	  18.8%	   14	  (121)	  –	  11.6%	  
DZF	   87	  (383)	  –	  22.7%	   39	  (250)	  –	  15.6%	   30	  (132)	  –	  22.7%	   10	  (43)	  –	  23.3%	  
DZO	   121	  (587)	  –	  20.6%	   80	  (409)	  –	  19.6%	   39	  (229)	  –	  17%	   5	  (54)	  –	  9.3%	  
MZ	   274	  (1463)	  –	  18.7%	   200	  (1071)	  -­‐18.7%	   104	  (616)	  –	  18.9%	   22	  (214)	  –	  10.3%	  
DZ	   271	  (1326)	  –	  20.4%	   155	  (910)	  –	  17%	   95	  (526)	  –	  18.1%	   19	  (143)	  –	  13.3%	  
Total	   545	  (2789)	  –	  19.5%	   355	  (1981)	  –	  17.9%	   199	  (1142)	  –	  17.4%	   41	  (357)	  –	  11.5%	  
Values	  represent	  percentage	  of	  the	  total	  sample	  reporting	  clinically	  significant	  insomnia.	  
DZ	  =	  all	  dizygotic	  twins;	  DZF	  =	  dizygotic	  female	  twins;	  DZM	  =	  dizygotic	  male	  twins;	  DZO	  =	  dizygotic	  
opposite	   sex	   twins;	   MZ	   =	   all	   monozygotic	   twins;	   MZF	   =	   monozygotic	   female	   twins;	   MZM	   =	  












Table	  3a.	  Cross	  twin	  correlations	  (and	  95%	  confidence	  intervals)	  for	  ratings	  of	  ‘clinically	  significant	  
insomnia’	  	  
	   Wave	  1	   Wave	  2	   Wave	  3	   Wave	  4	  
MZ	   0.33	  (0.19-­‐0.46)	   0.39	  (0.23-­‐0.53)	   0.14	  (-­‐0.11-­‐0.37)	   0.26	  (-­‐0.27-­‐0.68)	  
DZ	   0.10	  (-­‐0.05-­‐0.25)	   0.05	  (-­‐0.16-­‐0.25)	   0.06	  (-­‐0.20-­‐0.31)	   -­‐0.05	  (-­‐0.56-­‐0.50)	  
Table	  3b.	  Phenotypic	  correlations	  (and	  95%	  confidence	  intervals)	  for	  ratings	  of	  ‘clinically	  significant	  
insomnia’	  
	   Wave	  1	   Wave	  2	   Wave	  3	   Wave	  4	  
Wave	  1	   1	   	   	   	  
Wave	  2	   0.31	  (0.23-­‐0.39)	   1	   	   	  
Wave	  3	   0.04	  (-­‐0.09-­‐0.16)	   0.18	  (0.06-­‐0.30)	   1	   	  
Wave	  4	   -­‐0.08	  (-­‐0.31-­‐0.16)	   0.03	  (-­‐0.22-­‐0.28)	   0.38	  (0.14-­‐0.59)	   1	  
Table	  3c.	  Cross-­‐twin	  cross-­‐trait	  correlations	  (and	  95%	  confidence	  intervals)	  for	  ratings	  of	  ‘clinically	  
significant	  insomnia’	  	  (MZ	  below	  diagonal,	  DZ	  above	  diagonal)	  
	   Wave	  1	   Wave	  2	   Wave	  3	   Wave	  4	  
Wave	  1	   /	   -­‐0.09	  (-­‐0.23-­‐0.05)	   -­‐0.10	  (-­‐0.28-­‐0.09)	   0.29	  (-­‐0.06-­‐0.59)	  
Wave	  2	   0.25	  (0.14-­‐0.36)	   /	   0.11	  (-­‐0.08-­‐0.29)	   0.06	  (-­‐0.33-­‐0.44)	  
Wave	  3	   0.16	  (-­‐0.01-­‐0.32)	   0.16	  (-­‐0.00-­‐0.32)	   /	   -­‐0.10	  (-­‐0.47-­‐0.30)	  
Wave	  4	   0.18	  (-­‐0.12-­‐0.45)	   -­‐0.14	  (-­‐0.47-­‐0.22)	   0.23	  (-­‐0.10-­‐0.53)	   /	  








Table	  4.	  Fit	  statistics	  for	  univariate	  genetic	  model	  fitting	  analyses	  	  for	  ratings	  of	  ‘clinically	  
significant	  insomnia’	  
Fit	   	   Fit	  relative	  to	  saturated	  model	  
Model	   -­‐2LL	   df	   ∆χ2	   ∆df	   P	   AIC	  
WAVE	  1	   	   	   	   	   	   	  
1.	  Saturated	  	   2726.84	   2783	   	   	   	   	  
2.	  ACE	  	   2734.01	   2786	   7.17	   3	   0.07	   1.17	  
3.	  ADE	   2733.35	   2786	   6.51	   3	   0.09	   0.51	  
4.	  CE	   2738.42	   2787	   11.58	   4	   0.02	   3.58	  
5.	  DE	   2733.38	   2787	   6.54	   4	   0.16	   -­‐1.46	  
6.	  AE	   2734.01	   2787	   7.17	   4	   0.13	   -­‐0.83	  
WAVE	  2	   	   	   	   	   	   	  
1.	  Saturated	  	   1838.01	   1975	   	   	   	   	  
2.	  ACE	  	   1842.70	   1978	   4.69	   3	   0.20	   -­‐1.31	  
3.	  ADE	   1841.17	   1978	   3.16	   3	   0.37	   -­‐2.84	  
4.	  CE	   1847.77	   1979	   9.76	   4	   0.04	   1.76	  
5.	  DE	   1841.17	   1979	   3.16	   4	   0.53	   -­‐4.84	  
6.	  AE	   1842.70	   1979	   4.69	   4	   0.32	   -­‐3.31	  
WAVE	  3	   	   	   	   	   	   	  
1.	  Saturated	  	   1051.98	   1136	   	   	   	   	  
2.	  ACE	  	   1055.11	   1139	   3.13	   3	   0.37	   -­‐2.87	  
3.	  ADE	   1055.10	   1139	   3.12	   3	   0.37	   -­‐2.88	  
4.	  CE	   1055.31	   1140	   3.33	   4	   0.50	   -­‐4.67	  
5.	  DE	   1055.98	   1140	   3.15	   4	   0.53	   -­‐4.85	  
6.	  AE	   1055.11	   1140	   3.13	   4	   0.54	   -­‐4.87	  
WAVE	  4	   	   	   	   	   	   	  
1.	  Saturated	  	   249.39	   351	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2.	  ACE	  	   253.92	   354	   4.53	   3	   0.21	   -­‐1.47	  
3.	  ADE	   253.76	   354	   4.37	   3	   0.22	   -­‐1.63	  
4.	  CE	   254.21	   355	   4.82	   4	   0.31	   -­‐3.18	  
5.	  DE	   253.76	   355	   4.37	   4	   0.36	   -­‐3.63	  
6.	  AE	   253.92	   355	   4.53	   4	   0.34	   -­‐3.47	  
Best-­‐fitting	  model	  indicated	  in	  bold.	  
A	  =	  additive	  genetic	  influence;	  AIC	  =	  Akaike’s	  Information	  Criterion	  statistic	  (calculated	  
as	  χ2	  –	  2df);	  C	  =	  shared	  environmental	  influence;	  D	  =	  nonadditive	  genetic	  influence;	  E	  =	  
nonshared	   environmental	   influence;	   -­‐2LL	   =	   -­‐2*(log	   likelihood);	   df	   =	   degrees	   of	  
freedom;	   ∆χ2	   and	   ∆df	   =	   change	   in	   chi-­‐square	   statistic	   and	   corresponding	   degrees	   of	  
freedom	   (computed	   as	   the	   difference	   in	   likelihood	   and	  df	   between	   each	  model	   and	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